錦龍股份(000712.SZ):擬掛牌轉讓中山證券67.78%股份
格隆匯6月5日丨錦龍股份(000712.SZ)公佈,擬通過上海聯合產權交易所公開掛牌的方式轉讓所持有的中山證券有限責任公司(“中山證券”)全部1,206,393,810股股權(佔中山證券總股本的67.78%)。就本次股權交易事宜,公司擬於近日在上海聯合產權交易所預掛牌;預掛牌僅為信息預披露,目的在於徵尋標的股權意向受讓方,不構成交易要約。後續公司將開展本次股權交易的審計、評估和盡調工作。待相關工作完成後,公司董事會將審議確定本次交易的交易條件、轉讓底價等事項;在該等事項確定後,標的股權將在上海聯合產權交易所正式掛牌轉讓。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.